Search results
FDA investigating cancer risk linked to CAR-T cell therapy
BioPharma Dive via Yahoo Finance· 5 months agoThe Food and Drug Adminsitration is investigating whether CAR-T cell therapies like Novartis’...
CAR T-Cell Therapies Under FDA Watch on Reports of Malignancies
Zacks via Yahoo Finance· 5 months agoThe FDA has undertaken an investigation of T-cell malignancies in patients undergoing CAR T-cell...
Bristol Myers (BMY) Announces CAR T Cell Therapy Breyanzi Data
Zacks via Yahoo Finance· 10 months agoBristol Myers' (BMY) CAR T cell therapy Breyanzi (lisocabtagene maraleucel) shows deep and durable...
FDA warns of secondary cancer risk tied to CAR-T therapies that treat cancer
CNN via Yahoo News· 3 months agoThe US Food and Drug Administration has issued a new warning about the possible risk of secondary...
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell...
Benzinga via Yahoo Finance· 5 months agoTuesday, the FDA said it received reports of patients developing T-cell malignancies, including...
Gilead (GILD) Kite Reports Positive Data on CAR T-Cell Therapy
Zacks via Yahoo Finance· 1 year agoGilead Sciences’ GILD Kite announced encouraging three-year follow-up results from the ZUMA-3 study...
FDA says cancer treatment CAR-T therapy may cause cancer itself
Newsy via AOL· 3 months agoGrowing bacteria to create CAR-T therapy The Food and Drug Administration will require companies...
Europe Approves First CAR T-Cell Therapy For B-Cell Lymphoma In 30 Years to Improve Upon Standard of...
Benzinga via Yahoo Finance· 2 years agoThe European Commission approved Kite Pharma's, a Gilead Sciences Inc (NASDAQ: GILD) Yescarta...
US FDA seeks 'boxed warning' for CAR-T cancer therapies
Reuters via Yahoo News· 3 months ago(Reuters) -The U.S. health regulator on Monday asked a host of drugmakers, including Gilead...
Gilead's Flagship CAR T-cell Therapy Shows Improved Overall Survival In Pretreated Lymphoma Patients
Benzinga via Yahoo Finance· 1 year agoKite, a Gilead Science Inc (NASDAQ: GILD) company, announced the primary overall survival (OS)...